Roivant Sciences Ltd. (ROIV)
22.09
+0.75
(+3.51%)
USD |
NASDAQ |
Dec 12, 16:00
22.23
+0.14
(+0.63%)
After-Hours: 20:00
Roivant Sciences Total Liabilities (Quarterly): 257.14M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 68.48B |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 8.601M |
| Autolus Therapeutics Plc | 396.50M |
| Tiziana Life Sciences Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.063B |
| Shareholders Equity (Quarterly) | 4.362B |
| Debt to Equity Ratio | 0.0227 |
| Current Ratio | 33.70 |
| Net Debt Paydown Yield | 0.54% |